Structure

Physi-Chem Properties

Molecular Weight:  194.06
Volume:  189.018
LogP:  1.177
LogD:  0.818
LogS:  -1.797
# Rotatable Bonds:  0
TPSA:  77.76
# H-Bond Aceptor:  4
# H-Bond Donor:  3
# Rings:  2
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.528
Synthetic Accessibility Score:  3.139
Fsp3:  0.3
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.016
MDCK Permeability:  6.314351139735663e-06
Pgp-inhibitor:  0.003
Pgp-substrate:  0.053
Human Intestinal Absorption (HIA):  0.507
20% Bioavailability (F20%):  0.988
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.259
Plasma Protein Binding (PPB):  53.95885467529297%
Volume Distribution (VD):  0.828
Pgp-substrate:  47.835994720458984%

ADMET: Metabolism

CYP1A2-inhibitor:  0.477
CYP1A2-substrate:  0.32
CYP2C19-inhibitor:  0.053
CYP2C19-substrate:  0.087
CYP2C9-inhibitor:  0.062
CYP2C9-substrate:  0.687
CYP2D6-inhibitor:  0.057
CYP2D6-substrate:  0.288
CYP3A4-inhibitor:  0.065
CYP3A4-substrate:  0.166

ADMET: Excretion

Clearance (CL):  16.456
Half-life (T1/2):  0.773

ADMET: Toxicity

hERG Blockers:  0.013
Human Hepatotoxicity (H-HT):  0.098
Drug-inuced Liver Injury (DILI):  0.317
AMES Toxicity:  0.329
Rat Oral Acute Toxicity:  0.585
Maximum Recommended Daily Dose:  0.244
Skin Sensitization:  0.894
Carcinogencity:  0.426
Eye Corrosion:  0.03
Eye Irritation:  0.948
Respiratory Toxicity:  0.711

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC147757

Natural Product ID:  NPC147757
Common Name*:   6-Hydroxy-Isosclerone
IUPAC Name:   (4S)-4,6,8-trihydroxy-3,4-dihydro-2H-naphthalen-1-one
Synonyms:   6-Hydroxy-Isosclerone
Standard InCHIKey:  YIIXGDYMMKWBPB-ZETCQYMHSA-N
Standard InCHI:  InChI=1S/C10H10O4/c11-5-3-6-7(12)1-2-8(13)10(6)9(14)4-5/h3-4,7,11-12,14H,1-2H2/t7-/m0/s1
SMILES:  Oc1cc2[C@@H](O)CCC(=O)c2c(c1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL510767
PubChem CID:   44585560
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000048] Tetralins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25302 Viola philippica Species Violaceae Eukaryota n.a. n.a. n.a. PMID[14519932]
NPO32546 ymf 1.01029 n.a. n.a. n.a. n.a. n.a. n.a. PMID[18479163]
NPO28287 Magnaporthe oryzae Species Magnaporthaceae Eukaryota n.a. n.a. n.a. PMID[26258762]
NPO25302 Viola philippica Species Violaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO25302 Viola philippica Species Violaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO28287 Magnaporthe oryzae Species Magnaporthaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO3641 Polyporus tuberaster Species Polyporaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO16391 Protea neriifolia Species Proteaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO318 Glycosmis trichanthera Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO4567 Senecio chrysocoma Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO6773 Bryoria implexa Species Parmeliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO25302 Viola philippica Species Violaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT593 Organism Bursaphelenchus xylophilus Bursaphelenchus xylophilus Activity = 51.2 % PMID[450415]
NPT593 Organism Bursaphelenchus xylophilus Bursaphelenchus xylophilus Activity = 23.7 % PMID[450415]
NPT593 Organism Bursaphelenchus xylophilus Bursaphelenchus xylophilus Activity = 57.3 % PMID[450415]
NPT593 Organism Bursaphelenchus xylophilus Bursaphelenchus xylophilus Activity = 46.7 % PMID[450415]
NPT115 Organism Mycobacterium tuberculosis H37Ra Mycobacterium tuberculosis H37Ra MIC = 12.5 ug.mL-1 PMID[450416]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC147757 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.984 High Similarity NPC478190
0.9225 High Similarity NPC17843
0.9213 High Similarity NPC247250
0.9213 High Similarity NPC767
0.9173 High Similarity NPC190457
0.9127 High Similarity NPC10926
0.9111 High Similarity NPC474961
0.9111 High Similarity NPC137649
0.9062 High Similarity NPC179898
0.9055 High Similarity NPC8745
0.9048 High Similarity NPC13238
0.9037 High Similarity NPC204045
0.9037 High Similarity NPC305845
0.8992 High Similarity NPC120488
0.8992 High Similarity NPC92624
0.8992 High Similarity NPC102829
0.8978 High Similarity NPC244691
0.8978 High Similarity NPC471906
0.8976 High Similarity NPC201728
0.8976 High Similarity NPC477454
0.8976 High Similarity NPC262671
0.8971 High Similarity NPC135524
0.8952 High Similarity NPC473662
0.8952 High Similarity NPC216297
0.8952 High Similarity NPC7151
0.8939 High Similarity NPC44437
0.8939 High Similarity NPC282780
0.8939 High Similarity NPC166480
0.8923 High Similarity NPC259942
0.8915 High Similarity NPC41263
0.8906 High Similarity NPC473691
0.8889 High Similarity NPC268052
0.8881 High Similarity NPC170742
0.8864 High Similarity NPC40524
0.8864 High Similarity NPC213485
0.8864 High Similarity NPC267205
0.8864 High Similarity NPC139074
0.8815 High Similarity NPC175552
0.8815 High Similarity NPC475974
0.881 High Similarity NPC224273
0.881 High Similarity NPC143427
0.881 High Similarity NPC242895
0.881 High Similarity NPC73532
0.881 High Similarity NPC267552
0.881 High Similarity NPC19174
0.881 High Similarity NPC45438
0.881 High Similarity NPC115159
0.8806 High Similarity NPC235115
0.8806 High Similarity NPC254847
0.8797 High Similarity NPC474519
0.879 High Similarity NPC40649
0.879 High Similarity NPC209486
0.8779 High Similarity NPC62219
0.8759 High Similarity NPC244923
0.875 High Similarity NPC32360
0.875 High Similarity NPC143438
0.875 High Similarity NPC474655
0.8741 High Similarity NPC53414
0.8741 High Similarity NPC471905
0.8741 High Similarity NPC474849
0.8741 High Similarity NPC178467
0.8741 High Similarity NPC65837
0.8741 High Similarity NPC53206
0.8741 High Similarity NPC474771
0.8741 High Similarity NPC149372
0.874 High Similarity NPC133909
0.874 High Similarity NPC32032
0.8731 High Similarity NPC130899
0.8731 High Similarity NPC283590
0.8731 High Similarity NPC70859
0.8731 High Similarity NPC61153
0.873 High Similarity NPC146642
0.873 High Similarity NPC297186
0.8722 High Similarity NPC314048
0.8722 High Similarity NPC153783
0.8712 High Similarity NPC469526
0.8712 High Similarity NPC475042
0.8712 High Similarity NPC219892
0.8712 High Similarity NPC189823
0.8712 High Similarity NPC34070
0.8705 High Similarity NPC48762
0.8696 High Similarity NPC73061
0.8686 High Similarity NPC156872
0.8686 High Similarity NPC155205
0.8676 High Similarity NPC33144
0.8676 High Similarity NPC94248
0.8676 High Similarity NPC478200
0.8676 High Similarity NPC212693
0.8676 High Similarity NPC472403
0.8676 High Similarity NPC472602
0.8676 High Similarity NPC9121
0.8676 High Similarity NPC191835
0.8676 High Similarity NPC177307
0.8667 High Similarity NPC191976
0.8661 High Similarity NPC156139
0.8657 High Similarity NPC474394
0.8651 High Similarity NPC294037
0.8647 High Similarity NPC135801
0.8643 High Similarity NPC34482
0.8636 High Similarity NPC26697
0.8636 High Similarity NPC247477
0.8636 High Similarity NPC233056
0.8636 High Similarity NPC17840
0.8623 High Similarity NPC187843
0.8623 High Similarity NPC110810
0.8623 High Similarity NPC158634
0.8623 High Similarity NPC290550
0.8613 High Similarity NPC242994
0.8613 High Similarity NPC247409
0.8613 High Similarity NPC105456
0.8613 High Similarity NPC92655
0.8613 High Similarity NPC138099
0.8613 High Similarity NPC139634
0.8605 High Similarity NPC74507
0.8605 High Similarity NPC152525
0.8605 High Similarity NPC68756
0.8605 High Similarity NPC234890
0.8603 High Similarity NPC70380
0.8603 High Similarity NPC71256
0.8603 High Similarity NPC290030
0.8593 High Similarity NPC278375
0.8593 High Similarity NPC129752
0.8592 High Similarity NPC153417
0.8583 High Similarity NPC248363
0.8583 High Similarity NPC149246
0.8582 High Similarity NPC52407
0.8582 High Similarity NPC470570
0.8582 High Similarity NPC48036
0.8571 High Similarity NPC21599
0.8571 High Similarity NPC158222
0.8571 High Similarity NPC193703
0.8571 High Similarity NPC161617
0.8561 High Similarity NPC49108
0.856 High Similarity NPC230349
0.8551 High Similarity NPC181560
0.8551 High Similarity NPC169452
0.8551 High Similarity NPC158472
0.8551 High Similarity NPC203063
0.8551 High Similarity NPC183345
0.8531 High Similarity NPC477221
0.8529 High Similarity NPC223836
0.8529 High Similarity NPC118919
0.8529 High Similarity NPC315275
0.8521 High Similarity NPC290194
0.8519 High Similarity NPC175943
0.8516 High Similarity NPC196976
0.8516 High Similarity NPC198336
0.8516 High Similarity NPC215392
0.8511 High Similarity NPC257558
0.8511 High Similarity NPC83272
0.8507 High Similarity NPC175738
0.8507 High Similarity NPC70622
0.8504 High Similarity NPC159525
0.85 High Similarity NPC354984
0.85 High Similarity NPC469542
0.85 High Similarity NPC478202
0.85 High Similarity NPC472006
0.85 High Similarity NPC51106
0.85 High Similarity NPC238629
0.8489 Intermediate Similarity NPC472603
0.8489 Intermediate Similarity NPC246638
0.8489 Intermediate Similarity NPC313123
0.8489 Intermediate Similarity NPC90411
0.8489 Intermediate Similarity NPC472904
0.8489 Intermediate Similarity NPC472605
0.8489 Intermediate Similarity NPC472604
0.8489 Intermediate Similarity NPC53649
0.8489 Intermediate Similarity NPC472035
0.8489 Intermediate Similarity NPC478217
0.8489 Intermediate Similarity NPC182421
0.8489 Intermediate Similarity NPC478201
0.8485 Intermediate Similarity NPC95537
0.8483 Intermediate Similarity NPC470337
0.8483 Intermediate Similarity NPC470340
0.8483 Intermediate Similarity NPC268992
0.8483 Intermediate Similarity NPC470338
0.8483 Intermediate Similarity NPC51824
0.8483 Intermediate Similarity NPC474843
0.8483 Intermediate Similarity NPC113608
0.8478 Intermediate Similarity NPC472903
0.8478 Intermediate Similarity NPC88269
0.8478 Intermediate Similarity NPC275356
0.8478 Intermediate Similarity NPC52358
0.8478 Intermediate Similarity NPC162939
0.8478 Intermediate Similarity NPC471819
0.8473 Intermediate Similarity NPC267846
0.8472 Intermediate Similarity NPC147735
0.8472 Intermediate Similarity NPC202595
0.8467 Intermediate Similarity NPC135837
0.8467 Intermediate Similarity NPC193792
0.8467 Intermediate Similarity NPC301915
0.8467 Intermediate Similarity NPC261292
0.8456 Intermediate Similarity NPC182496
0.8456 Intermediate Similarity NPC161632
0.8456 Intermediate Similarity NPC290803
0.8456 Intermediate Similarity NPC180905
0.8451 Intermediate Similarity NPC107625
0.845 Intermediate Similarity NPC91105
0.845 Intermediate Similarity NPC283514
0.8444 Intermediate Similarity NPC37299

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC147757 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8806 High Similarity NPD1509 Clinical (unspecified phase)
0.8667 High Similarity NPD651 Clinical (unspecified phase)
0.8647 High Similarity NPD943 Approved
0.8345 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.831 Intermediate Similarity NPD7390 Discontinued
0.8261 Intermediate Similarity NPD1510 Phase 2
0.8258 Intermediate Similarity NPD1470 Approved
0.8231 Intermediate Similarity NPD1201 Approved
0.8189 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.8143 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8143 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8102 Intermediate Similarity NPD1240 Approved
0.8085 Intermediate Similarity NPD1549 Phase 2
0.7986 Intermediate Similarity NPD1607 Approved
0.7931 Intermediate Similarity NPD1511 Approved
0.7895 Intermediate Similarity NPD9269 Phase 2
0.7877 Intermediate Similarity NPD2532 Approved
0.7877 Intermediate Similarity NPD2534 Approved
0.7877 Intermediate Similarity NPD2533 Approved
0.7867 Intermediate Similarity NPD1934 Approved
0.7863 Intermediate Similarity NPD9268 Approved
0.7852 Intermediate Similarity NPD4380 Phase 2
0.7823 Intermediate Similarity NPD1512 Approved
0.7815 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7786 Intermediate Similarity NPD230 Phase 1
0.7755 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD6959 Discontinued
0.7697 Intermediate Similarity NPD7819 Suspended
0.7697 Intermediate Similarity NPD2801 Approved
0.7692 Intermediate Similarity NPD5408 Approved
0.7692 Intermediate Similarity NPD5405 Approved
0.7692 Intermediate Similarity NPD5404 Approved
0.7692 Intermediate Similarity NPD5406 Approved
0.7603 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7597 Intermediate Similarity NPD3882 Suspended
0.7591 Intermediate Similarity NPD1164 Approved
0.758 Intermediate Similarity NPD6232 Discontinued
0.7569 Intermediate Similarity NPD2796 Approved
0.7548 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7547 Intermediate Similarity NPD7473 Discontinued
0.7534 Intermediate Similarity NPD2800 Approved
0.7532 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7517 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3818 Discontinued
0.7484 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD6166 Phase 2
0.7483 Intermediate Similarity NPD3750 Approved
0.7448 Intermediate Similarity NPD2935 Discontinued
0.7448 Intermediate Similarity NPD1551 Phase 2
0.7436 Intermediate Similarity NPD3749 Approved
0.7422 Intermediate Similarity NPD74 Approved
0.7422 Intermediate Similarity NPD9266 Approved
0.7372 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD9493 Approved
0.7346 Intermediate Similarity NPD7054 Approved
0.7344 Intermediate Similarity NPD9267 Approved
0.7344 Intermediate Similarity NPD9263 Approved
0.7344 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.7344 Intermediate Similarity NPD9264 Approved
0.7333 Intermediate Similarity NPD6799 Approved
0.7325 Intermediate Similarity NPD7075 Discontinued
0.7308 Intermediate Similarity NPD3817 Phase 2
0.7308 Intermediate Similarity NPD5402 Approved
0.7301 Intermediate Similarity NPD7074 Phase 3
0.7301 Intermediate Similarity NPD7472 Approved
0.7285 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.728 Intermediate Similarity NPD1242 Phase 1
0.7273 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD3300 Phase 2
0.7259 Intermediate Similarity NPD9545 Approved
0.7256 Intermediate Similarity NPD6797 Phase 2
0.725 Intermediate Similarity NPD5711 Approved
0.725 Intermediate Similarity NPD5710 Approved
0.7244 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD1465 Phase 2
0.7241 Intermediate Similarity NPD6651 Approved
0.7233 Intermediate Similarity NPD5494 Approved
0.7226 Intermediate Similarity NPD7411 Suspended
0.7212 Intermediate Similarity NPD7251 Discontinued
0.7206 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD3764 Approved
0.7179 Intermediate Similarity NPD6801 Discontinued
0.7169 Intermediate Similarity NPD7808 Phase 3
0.7162 Intermediate Similarity NPD2344 Approved
0.7161 Intermediate Similarity NPD6599 Discontinued
0.7143 Intermediate Similarity NPD3748 Approved
0.7134 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD5844 Phase 1
0.7099 Intermediate Similarity NPD4750 Phase 3
0.7097 Intermediate Similarity NPD3226 Approved
0.7095 Intermediate Similarity NPD6100 Approved
0.7095 Intermediate Similarity NPD6099 Approved
0.7092 Intermediate Similarity NPD1203 Approved
0.709 Intermediate Similarity NPD9281 Approved
0.7087 Intermediate Similarity NPD940 Approved
0.7087 Intermediate Similarity NPD846 Approved
0.7086 Intermediate Similarity NPD6190 Approved
0.7083 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD920 Approved
0.7078 Intermediate Similarity NPD5403 Approved
0.7073 Intermediate Similarity NPD3751 Discontinued
0.7059 Intermediate Similarity NPD5401 Approved
0.7059 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD2346 Discontinued
0.7044 Intermediate Similarity NPD7768 Phase 2
0.7031 Intermediate Similarity NPD9261 Approved
0.7029 Intermediate Similarity NPD2932 Approved
0.7029 Intermediate Similarity NPD3019 Approved
0.7027 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD6559 Discontinued
0.6977 Remote Similarity NPD1237 Approved
0.6974 Remote Similarity NPD2309 Approved
0.6962 Remote Similarity NPD37 Approved
0.6954 Remote Similarity NPD2654 Approved
0.6954 Remote Similarity NPD1243 Approved
0.6939 Remote Similarity NPD447 Suspended
0.6936 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6933 Remote Similarity NPD3787 Discontinued
0.6929 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6928 Remote Similarity NPD643 Clinical (unspecified phase)
0.6918 Remote Similarity NPD520 Approved
0.6913 Remote Similarity NPD2799 Discontinued
0.6908 Remote Similarity NPD3400 Discontinued
0.6908 Remote Similarity NPD4628 Phase 3
0.6901 Remote Similarity NPD8150 Discontinued
0.6879 Remote Similarity NPD9717 Approved
0.6875 Remote Similarity NPD9494 Approved
0.6871 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6871 Remote Similarity NPD1613 Approved
0.6871 Remote Similarity NPD1247 Approved
0.6864 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6849 Remote Similarity NPD2313 Discontinued
0.6845 Remote Similarity NPD5953 Discontinued
0.6842 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6832 Remote Similarity NPD4965 Approved
0.6832 Remote Similarity NPD4966 Approved
0.6832 Remote Similarity NPD4967 Phase 2
0.6826 Remote Similarity NPD7286 Phase 2
0.6824 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6809 Remote Similarity NPD1610 Phase 2
0.6806 Remote Similarity NPD2798 Approved
0.6788 Remote Similarity NPD3926 Phase 2
0.6781 Remote Similarity NPD3027 Phase 3
0.6772 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6765 Remote Similarity NPD36 Approved
0.6765 Remote Similarity NPD4955 Approved
0.6765 Remote Similarity NPD5028 Approved
0.6765 Remote Similarity NPD4954 Approved
0.6765 Remote Similarity NPD5026 Approved
0.6765 Remote Similarity NPD5034 Approved
0.6763 Remote Similarity NPD1548 Phase 1
0.6761 Remote Similarity NPD6534 Approved
0.6761 Remote Similarity NPD6535 Approved
0.6755 Remote Similarity NPD9570 Approved
0.6748 Remote Similarity NPD6234 Discontinued
0.6748 Remote Similarity NPD919 Approved
0.6736 Remote Similarity NPD3094 Phase 2
0.6735 Remote Similarity NPD411 Approved
0.6731 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6726 Remote Similarity NPD6020 Phase 2
0.6725 Remote Similarity NPD8312 Approved
0.6725 Remote Similarity NPD8313 Approved
0.6725 Remote Similarity NPD5035 Approved
0.6712 Remote Similarity NPD6832 Phase 2
0.6711 Remote Similarity NPD1471 Phase 3
0.6706 Remote Similarity NPD5030 Phase 2
0.6705 Remote Similarity NPD5037 Approved
0.6705 Remote Similarity NPD5038 Approved
0.669 Remote Similarity NPD422 Phase 1
0.6689 Remote Similarity NPD6663 Approved
0.6688 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6777 Approved
0.6667 Remote Similarity NPD4363 Phase 3
0.6667 Remote Similarity NPD6780 Approved
0.6667 Remote Similarity NPD1283 Approved
0.6667 Remote Similarity NPD6776 Approved
0.6667 Remote Similarity NPD1876 Approved
0.6667 Remote Similarity NPD6779 Approved
0.6667 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6782 Approved
0.6667 Remote Similarity NPD6778 Approved
0.6667 Remote Similarity NPD6781 Approved
0.6667 Remote Similarity NPD4360 Phase 2
0.6649 Remote Similarity NPD8151 Discontinued
0.6648 Remote Similarity NPD7699 Phase 2
0.6648 Remote Similarity NPD7700 Phase 2
0.6647 Remote Similarity NPD5036 Approved
0.6646 Remote Similarity NPD6844 Discontinued
0.6646 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6644 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6644 Remote Similarity NPD5736 Approved
0.6643 Remote Similarity NPD3091 Approved
0.6643 Remote Similarity NPD1608 Approved
0.6643 Remote Similarity NPD3972 Approved
0.663 Remote Similarity NPD6973 Clinical (unspecified phase)
0.6629 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6627 Remote Similarity NPD7229 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data